Onderneming Ind-Swift Laboratories Limited Bombay S.E.
Aandelen
INDSWFTLAB
INE915B01019
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
115,9 INR | -6,00% | -7,11% | +11,52% |
Vakgebied
Aantal werknemers: 1 496
Verkoop per activiteit
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceuticals - Manufactured
99,6
%
| 10 375 | 99,9 % | 12 029 | 99,6 % | +15,94% |
Pharmaceuticals - Traded
0,4
%
| 11 | 0,1 % | 44 | 0,4 % | +297,99% |
Services
0,0
%
| 1 | 0,0 % | 0 | 0,0 % | -67,69% |
Verkoop per regio
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
International
77,6
%
| 7 960 | 76,6 % | 9 374 | 77,6 % | +17,76% |
India
22,4
%
| 2 427 | 23,4 % | 2 699 | 22,4 % | +11,22% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Navrattan Munjal
CEO | Chief Executive Officer | 72 | 04-01-95 |
Himanshu Jain
CEO | Chief Executive Officer | 41 | - |
Gagan Aggarwal
DFI | Director of Finance/CFO | - | 29-09-18 |
Vijay Singla
COO | Chief Operating Officer | 49 | - |
Pardeep Verma
CMP | Compliance Officer | - | - |
Lalit K. Wadhwa
COO | Chief Operating Officer | - | 16-06-11 |
Varun Chhabra
SAM | Sales & Marketing | - | - |
Ashok Prasad
PRN | Corporate Officer/Principal | - | - |
Sales & Marketing | - | - | |
Vikas Narendra
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Himanshu Jain
CEO | Chief Executive Officer | 41 | - |
Navrattan Munjal
CEO | Chief Executive Officer | 72 | 04-01-95 |
Director/Board Member | 68 | 31-08-09 | |
Rishav Mehta
BRD | Director/Board Member | 33 | 23-03-10 |
Director/Board Member | 74 | 31-12-14 | |
Neerja Chathley
BRD | Director/Board Member | 69 | 10-05-19 |
Sahil Munjal
BRD | Director/Board Member | 43 | 13-02-20 |
Director/Board Member | 67 | 23-06-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 59 086 918 | 19 416 499 ( 32,86 %) | 0 | 32,86 % |
Bedrijfsgegevens
Ind-Swift Laboratories Ltd.
SCO 850, Shivalik Enclave NAC
160101, Manimajra
+91 17 2506 1850
http://www.indswiftlabs.comSector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+19,98% | 43,48 mld. | |
+20,67% | 22,65 mld. | |
+14,56% | 14,73 mld. | |
+14,32% | 13,79 mld. | |
+44,72% | 12,04 mld. | |
-8,37% | 7,08 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+11,90% | 5,47 mld. |
- Beurs
- Aandelen
- Koers INDSWFTLAB
- Koers INDSWFTLAB
- Onderneming Ind-Swift Laboratories Limited